| Ident. | Authors (with country if any) | Title |
|---|
| 000029 (2021) |
Maurizio Koch | [2020: Evidence-Based Medicine odyssey. The fall and rise of evidence-based medicine in the year of coronavirus.] |
| 000130 (2021) |
Yudibeth Sixto-L Pez [Mexique] ; José Correa-Basurto [Mexique] ; Martiniano Bello [Mexique] ; Bruno Landeros-Rivera [France] ; Jose Antonio Garz N-Tiznado [Mexique] ; Sarita Monta O [Mexique] | Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population. |
| 000137 (2021) |
Ça La Begüm Apayd N [Turquie] ; Gözde Ç Nar [Turquie] ; Gökçe Cihan-Üstünda [Turquie] | Small-molecule antiviral agents in ongoing clinical trials for COVID-19. |
| 000146 (2021) |
Rahul Sharma [Inde] ; Dharmendra Khokhar [Inde] ; Bhanushree Gupta [Inde] ; Purnendu Saxena [Inde] ; Kallol Kumar Ghosh [Inde] ; Arvind Kumar Geda [Inde] ; Kamil Kuca | Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics. |
| 000167 (2021) |
Masoomeh Sofian [Iran] ; Ali Akbar Velayati [Iran] ; Mohammad Banifazl [Iran] ; Fatemeh Fotouhi [Iran] ; Mona Sadat Larijani [Iran] ; Neda Afzali [Iran] ; Amitis Ramezani [Iran] | SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms. |
| 000249 (2021) |
Bianza Moise Bakadia ; Feng He [République populaire de Chine] ; Tiatou Souho [Togo] ; Lallepak Lamboni [Togo] ; Muhammad Wajid Ullah [République populaire de Chine] ; Biaou Ode Boni [République populaire de Chine] ; Abeer Ahmed Qaed Ahmed [République populaire de Chine] ; Biampata Mutu Mukole ; Guang Yang [République populaire de Chine] | Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine. |
| 000299 (2021) |
Marko Boban [Croatie] | Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments. |
| 000307 (2021) |
Shweta A. More [Inde] ; Akshay S. Patil [États-Unis] ; Nikhil S. Sakle [Inde] ; Santosh N. Mokale [Inde] | Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs. |
| 000311 (2021) |
Aitebiremen Gift Omokhua-Uyi [Afrique du Sud] ; Johannes Van Staden [Afrique du Sud] | Natural product remedies for COVID-19: A focus on safety. |
| 000327 (2021) |
Yashwant Kumar Ratre [Inde] ; Namrata Kahar [Inde] ; L V K S. Bhaskar [Inde] ; Antaripa Bhattacharya [Italie] ; Henu Kumar Verma [Italie] | Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective. |
| 000339 (2021) |
Ritwick Mondal [Inde] ; Upasana Ganguly [Inde] ; Shramana Deb [Inde] ; Gourav Shome [Inde] ; Subhasish Pramanik [Inde] ; Deebya Bandyopadhyay [Inde] ; Durjoy Lahiri [Inde] | Meningoencephalitis associated with COVID-19: a systematic review. |
| 000358 (2021) |
Hassan Askari [Iran] ; Nima Sanadgol [Iran, Brésil] ; Asaad Azarnezhad [Iran] ; Amir Tajbakhsh [Iran] ; Hossein Rafiei [Canada] ; Ali Reza Safarpour [Iran] ; Seyed Mohammad Gheibihayat [Iran] ; Ehsan Raeis-Abdollahi [Iran] ; Amir Savardashtaki [Iran] ; Ali Ghanbariasad [Iran] ; Navid Omidifar [Iran] | Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives. |
| 000396 (2021) |
Agata Blasiak ; Jhin Jieh Lim ; Shirley Gek Kheng Seah ; Theodore Kee ; Alexandria Remus ; De Hoe Chye ; Pui San Wong ; Lissa Hooi ; Anh T L. Truong ; Nguyen Le ; Conrad E Z. Chan ; Rishi Desai ; Xianting Ding ; Brendon J. Hanson ; Edward Kai-Hua Chow ; Dean Ho | IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development. |
| 000400 (2021) |
Yao Chen ; Mei-Xiu Li ; Guo-Dong Lu ; Han-Ming Shen [République populaire de Chine, Singapour] ; Jing Zhou [Singapour] | Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery. |
| 000492 (2021) |
Reshma Golamari [États-Unis] ; Neeru Kapoor [Inde] ; Tanuja Devaraj [États-Unis] ; Nitasa Sahu [États-Unis] ; Courtney Kramer [États-Unis] ; Rohit Jain [États-Unis] | Experimental therapies under investigation for COVID-19. |
| 000571 (2021) |
Mukesh Kumar [Inde] ; Jitender Madan [Inde] ; Rupinder Kaur Sodhi [Inde] ; Shashi Bala Singh [Inde] ; Anju Katyal [Inde] | Decoding the silent walk of COVID-19: Halting its spread using old bullets. |
| 000609 (2021) |
Jagdish Prasad Meena [Inde] ; Aditya Kumar Gupta [Inde] ; Pranay Tanwar [Inde] ; Kana Ram Jat [Inde] ; Ravindra Mohan Pandey [Inde] ; Rachna Seth [Inde] | Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review. |
| 000643 (2021) |
Tzu-Chuan Ho [Taïwan] ; Yung-Hsuan Wang [Taïwan] ; Yi-Ling Chen [Taïwan] ; Wan-Chi Tsai [Taïwan] ; Che-Hsin Lee [Taïwan] ; Kuo-Pin Chuang [Taïwan] ; Yi-Ming Arthur Chen [Taïwan] ; Cheng-Hui Yuan [Singapour] ; Sheng-Yow Ho [Taïwan] ; Ming-Hui Yang [Taïwan] ; Yu-Chang Tyan [Taïwan] | Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19. |
| 000644 (2021) |
Sultan A M. Saghir [Jordanie] ; Naif A. Algabri [Yémen, Djibouti] ; Mahmoud M. Alagawany [Égypte] ; Youssef A. Attia [Égypte] ; Salem R. Alyileili [Émirats arabes unis] ; Shaaban S. Elnesr [Égypte] ; Manal E. Shafi ; Omar Y A. Al-Shargi ; Nader Al-Balagi ; Abdullah S. Alwajeeh [Qatar] ; Omar S A. Alsalahi [Yémen] ; Amlan K. Patra [Inde] ; Asmaa F. Khafaga [Égypte] ; Ahmed Negida [Royaume-Uni, Égypte] ; Ahmed Noreldin [Égypte] ; Wesam Al-Amarat [Jordanie] ; Amer A. Almaiman ; Khaled A. El-Tarabily [Émirats arabes unis, Australie] ; Mohamed E. Abd El-Hack [Égypte] | Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review. |
| 000645 (2021) |
Riadh Badraoui [Arabie saoudite, Tunisie] ; Mohd Adnan [Arabie saoudite] ; Fevzi Bardakci [Arabie saoudite, Turquie] ; Mousa M. Alreshidi [Arabie saoudite] | Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism. |
| 000666 (2021) |
C T Dhanya Raj [Inde] ; Dinesh Kumar Kandaswamy [Inde, Royaume-Uni] ; Ravi Chandra Sekhara Reddy Danduga [Inde] ; Raju Rajasabapathy [Inde] ; Rathinam Arthur James [Inde] | COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics-a review. |
